Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma

Title
Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma
Authors
Keywords
Glioma, Dendritic cell, Chemoimmunotherapy, Temozolomide, Chemoresistance
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 65, Issue 12, Pages 1499-1509
Publisher
Springer Nature
Online
2016-09-29
DOI
10.1007/s00262-016-1905-7

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search